Known and potential molecules associated with altered B cell development leading to predominantly antibody deficiencies
- PMID: 34181780
- DOI: 10.1111/pai.13589
Known and potential molecules associated with altered B cell development leading to predominantly antibody deficiencies
Abstract
Predominantly antibody deficiencies (PADs) encompass a heterogeneous group of disorders characterized by low immunoglobulin serum levels in the presence or absence of peripheral B cells. Clinical presentation of affected patients may include recurrent respiratory and gastrointestinal infections, invasive infections, autoimmune manifestations, allergic reactions, lymphoproliferation, and increased susceptibility to malignant transformation. In the last decades, several genetic alterations affecting B-cell development/maturation have been identified as causative of several forms of PADs, adding important information on the genetic background of PADs, which in turn should lead to a better understanding of these disorders and precise clinical management of affected patients. This review aimed to present a comprehensive overview of the known and potentially involved molecules in the etiology of PADs to elucidate the pathogenesis of these disorders and eventually offer a better prognosis for affected patients.
Keywords: B-cell development; humoral immunity; immunoglobulin class switch recombination; inborn errors of immunity; predominantly antibody deficiencies; primary immunodeficiency.
© 2021 The Authors. Pediatric Allergy and Immunology published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.
Comment in
-
Comments on metabolomics in asthma and atopic dermatitis, and patient care during the COVID-19 pandemic.Pediatr Allergy Immunol. 2021 Nov;32(8):1597-1600. doi: 10.1111/pai.13664. Pediatr Allergy Immunol. 2021. PMID: 34719820 Free PMC article. No abstract available.
References
REFERENCES
-
- Tangye SG, Al-Herz W, Bousfiha A, et al. Human inborn errors of immunity: 2019 update on the classification from the international union of immunological societies expert committee. J Clin Immunol. 2020;40(1):24-64.
-
- Smith T, Cunningham-Rundles C. Primary B-cell immunodeficiencies. Hum Immunol. 2019;80(6):351-362.
-
- Abolhassani H, Parvaneh N, Rezaei N, Hammarstrom L, Aghamohammadi A. Genetic defects in B-cell development and their clinical consequences. J Investig Allergol Clin Immunol. 2014;24(1):6-22.
-
- Azizi G, Yazdani R. Predominantly antibody deficiencies. Immunol Genet J. 2018;1:52-80.
-
- Azizi G, Abolhassani H, Asgardoon MH, et al. The use of immunoglobulin therapy in primary immunodeficiency diseases. Endocr Metab Immune Disord Drug Targets. 2016;16(2):80-88.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
